What type of prostate cancer is Erleada used to treat?
Medically reviewed by Drugs.com Last updated on Sep 19, 2019.
Official Answerby Drugs.com
Metastatic castration-sensitive prostate cancer (mCSPC) refers to prostate cancer that still responds to androgen deprivation therapy (ADT) and has spread to other parts of the body.
Non-metastatic castration-resistant prostate cancer (NM-CRPC) refers to prostate cancer that no longer responds to androgen deprivation therapy (ADT) or surgical treatments that lower testosterone, but has not yet been discovered in other parts of the body.
Erleada is an androgen receptor inhibitor. It works by blocking the effect of androgens on the tumor. Androgens, such as testosterone, can promote tumor growth.
Erleada is taken orally, once daily, with or without food.
Related Medical Questions
- Oxycodone vs hydrocodone - What's the difference between them?
- What type of cancer is Tecentriq used to treat?
- Vicodin vs Percocet: What's the difference?
- What type of cancer is Rubraca used to treat?
- What drugs are contained in Vyxeos?
- What are the side effects of marijuana?
- What type of lung cancer is Vizimpro used to treat?